Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
63
Number of overlapping holdings
17.6%
% of FHLC's 372 holdings also in IXJ
58.3%
% of IXJ's 113 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus IXJ)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in FHLC |
Weight in IXJ |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 10.2% | 8.5% | 8.5% | |
UNITEDHEALTH GROUP INC | 7.3% | 5.7% | 5.7% | |
JOHNSON & JOHNSON | 6.3% | 4.7% | 4.7% | |
MERCK & CO. INC. | 5.2% | 4.5% | 4.5% | |
ABBVIE INC | 5.1% | 4.1% | 4.1% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to IXJ
ELI LILLY & CO | 1.7% | |
JOHNSON & JOHNSON | 1.6% | |
UNITEDHEALTH GROUP INC | 1.6% | |
ABBVIE INC | 1.0% | |
MERCK & CO. INC. | 0.8% | |
DANAHER CORP | 0.7% | |
ABBOTT LABORATORIES | 0.7% | |
THERMO FISHER SCIENTIFIC INC | 0.6% | |
VEEVA SYSTEMS INC-CLASS A | 0.5% | |
AMGEN INC | 0.5% |
FHLC Underweight Relative to IXJ
NOVO NORDISK A/S-B | -5.5% | |
ASTRAZENECA PLC | -2.8% | |
NOVARTIS AG | -2.7% | |
ROCHE HOLDING LTD | -2.3% | |
SANOFI-AVENTIS | -1.4% | |
CSL LIMITED | -1.2% | |
ESSILOR INTERNATIONAL | -0.9% | |
DAIICHI SANKYO CO LTD | -0.8% | |
LONZA GROUP AG-REG | -0.6% | |
TAKEDA PHARMACEUTICAL CO LTD | -0.6% |